Song J, Lee M, Cha E, Lee K, Kim J, Kim J
Korean J Clin Oncol. 2023; 18(1):1-10.
PMID: 36945334
PMC: 9942767.
DOI: 10.14216/kjco.22001.
Sim H, Galanis E, Khasraw M
Cancers (Basel). 2022; 14(4).
PMID: 35205750
PMC: 8869934.
DOI: 10.3390/cancers14041003.
Taiana E, Gallo Cantafio M, Favasuli V, Bandini C, Viglietto G, Piva R
Cancers (Basel). 2021; 13(9).
PMID: 33924959
PMC: 8125142.
DOI: 10.3390/cancers13092127.
Cipriano E, Mesquita A
Breast Cancer (Auckl). 2021; 15:11782234211002491.
PMID: 33814914
PMC: 7989121.
DOI: 10.1177/11782234211002491.
Chen Z, Chen J
J Zhejiang Univ Sci B. 2021; 22(1):1-20.
PMID: 33448183
PMC: 7818012.
DOI: 10.1631/jzus.B2000356.
BARD1 and Breast Cancer: The Possibility of Creating Screening Tests and New Preventive and Therapeutic Pathways for Predisposed Women.
Sniadecki M, Brzezinski M, Darecka K, Klasa-Mazurkiewicz D, Poniewierza P, Krzeszowiec M
Genes (Basel). 2020; 11(11).
PMID: 33114377
PMC: 7693009.
DOI: 10.3390/genes11111251.
Radiosensitization by Hyperthermia: The Effects of Temperature, Sequence, and Time Interval in Cervical Cell Lines.
Mei X, Ten Cate R, van Leeuwen C, Rodermond H, de Leeuw L, Dimitrakopoulou D
Cancers (Basel). 2020; 12(3).
PMID: 32138173
PMC: 7139900.
DOI: 10.3390/cancers12030582.
Autophagy, Cellular Aging and Age-related Human Diseases.
Cheon S, Kim H, Rubinsztein D, Lee J
Exp Neurobiol. 2020; 28(6):643-657.
PMID: 31902153
PMC: 6946111.
DOI: 10.5607/en.2019.28.6.643.
The double-edged sword of cancer mutations: exploiting neoepitopes for the fight against cancer.
Alvarado-Cruz I, Meas R, Paluri S, Carufe K, Khan M, Sweasy J
Mutagenesis. 2019; 35(1):69-78.
PMID: 31880305
PMC: 7016206.
DOI: 10.1093/mutage/gez049.
Quantitating repair protein accumulation at DNA lesions: Past, present, and future.
Mahadevan J, Bowerman S, Luger K
DNA Repair (Amst). 2019; 81:102650.
PMID: 31315816
PMC: 6884943.
DOI: 10.1016/j.dnarep.2019.102650.
Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia.
Elming P, Sorensen B, Oei A, Franken N, Crezee J, Overgaard J
Cancers (Basel). 2019; 11(1).
PMID: 30634444
PMC: 6356970.
DOI: 10.3390/cancers11010060.
An Insight into Ginsenoside Metabolite Compound K as a Potential Tool for Skin Disorder.
Kim E, Kim W
Evid Based Complement Alternat Med. 2018; 2018:8075870.
PMID: 30046346
PMC: 6036801.
DOI: 10.1155/2018/8075870.
Differentiated embryo chondrocyte plays a crucial role in DNA damage response via transcriptional regulation under hypoxic conditions.
Nakamura H, Bono H, Hiyama K, Kawamoto T, Kato Y, Nakanishi T
PLoS One. 2018; 13(2):e0192136.
PMID: 29466367
PMC: 5821451.
DOI: 10.1371/journal.pone.0192136.
Sensitizing thermochemotherapy with a PARP1-inhibitor.
Oei A, Vriend L, van Leeuwen C, Rodermond H, Ten Cate R, Westermann A
Oncotarget. 2016; 8(10):16303-16312.
PMID: 27557507
PMC: 5369964.
DOI: 10.18632/oncotarget.11422.
The Genomes of Three Uneven Siblings: Footprints of the Lifestyles of Three Trichoderma Species.
Schmoll M, Dattenbock C, Carreras-Villasenor N, Mendoza-Mendoza A, Tisch D, Aleman M
Microbiol Mol Biol Rev. 2016; 80(1):205-327.
PMID: 26864432
PMC: 4771370.
DOI: 10.1128/MMBR.00040-15.
Multiple target drug cocktail design for attacking the core network markers of four cancers using ligand-based and structure-based virtual screening methods.
Wong Y, Lin C, Chen T, Chen C, Jiang P, Lai Y
BMC Med Genomics. 2015; 8 Suppl 4:S4.
PMID: 26680552
PMC: 4682379.
DOI: 10.1186/1755-8794-8-S4-S4.
Protective Effect of Diphlorethohydroxycarmalol against Ultraviolet B Radiation-Induced DNA Damage by Inducing the Nucleotide Excision Repair System in HaCaT Human Keratinocytes.
Piao M, Hewage S, Han X, Kang K, Kang H, Lee N
Mar Drugs. 2015; 13(9):5629-41.
PMID: 26404324
PMC: 4584344.
DOI: 10.3390/md13095629.
The potential of PARP inhibitors in neuro-oncology.
Carruthers R, Chalmers A
CNS Oncol. 2014; 1(1):85-97.
PMID: 25054302
PMC: 6176825.
DOI: 10.2217/cns.12.13.
A novel mechanism inducing genome instability in Kaposi's sarcoma-associated herpesvirus infected cells.
Jackson B, Noerenberg M, Whitehouse A
PLoS Pathog. 2014; 10(5):e1004098.
PMID: 24788796
PMC: 4006916.
DOI: 10.1371/journal.ppat.1004098.
Association of single-nucleotide polymorphisms in ERCC1 and ERCC2 with glioma risk.
Hui L, Yue S, Gao G, Chang H, Li X
Tumour Biol. 2014; 35(8):7451-7.
PMID: 24782032
DOI: 10.1007/s13277-014-1969-y.
